CSF penetration and pharmacokinetics of midazolam
✍ Scribed by S. Sjövall; J. Kanto; J. -J. Himberg; M. Hovi-Viander; M. Salo
- Publisher
- Springer
- Year
- 1983
- Tongue
- English
- Weight
- 493 KB
- Volume
- 25
- Category
- Article
- ISSN
- 0031-6970
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
The interaction between roxithromycin and midazolam was investigated in a double-blind, randomised crossover study of two phases. Ten healthy volunteers were given roxithromycin (300 mg) or placebo once daily for 6 days. On the sixth day they ingested 15 mg midazolam. Plasma samples were collected a
Midazolam is a water soluble benzodiazepine, with a short elimination half-life in adults and children. An IV bolus of midazolam 0.2 mg.kg-1 was administered to 10 critically ill neonates receiving intensive care who required sedation. The plasma clearance was 6.85 ml.min-1 and the elimination half-